Caxton Associates LP Vericel Corp Transaction History
Caxton Associates LP
- $1.78 Billion
- Q1 2024
A detailed history of Caxton Associates LP transactions in Vericel Corp stock. As of the latest transaction made, Caxton Associates LP holds 9,480 shares of VCEL stock, worth $434,942. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,480Holding current value
$434,942% of portfolio
0.03%Shares
3 transactions
Others Institutions Holding VCEL
# of Institutions
263Shares Held
48.9MCall Options Held
150KPut Options Held
128K-
Black Rock Inc. New York, NY7.97MShares$366 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.95MShares$227 Million4.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.41MShares$157 Million0.0% of portfolio
-
State Street Corp Boston, MA3.21MShares$147 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.33MShares$107 Million1.77% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.16B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...